June 13, 2018—Newly introduced legislation would demand accountability and transparency from drug manufacturers participating in the 340B drug pricing program. The bill, sponsored by Rep. Doris Matsui (D-Calif.), is the most significant pro-340B proposal in nearly a decade. Under the Matsui bill, known as the Stretching Entity Resources for Vulnerable Communities (SERV … [Read more...]